← All trials
NCT05096663
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 28, 2022
- Primary completion
- Feb 29, 2024
- Completion date
- Feb 28, 2025
- First posted
- Oct 27, 2021
- Last posted
- Oct 27, 2021
- Enrollment
- 478
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Southwest Oncology GroupLead sponsor
- National Cancer Institute (NCI)Collaborator
- Southwest Oncology GroupOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.